2 active trials 2 recruiting 2 Phase 3 1 disease areas
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06622057 | D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced… | Biliary Tract Cancer (BTC) | Recruiting | 2026-07-30 |
| Phase 2/3 | ||||
| NCT05065957 | Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With… | Biliary Tract Cancer | Recruiting | 2025-04-30 |